SYNPR | Synaptoporin | Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/51368/ihc_cell_selected_60x60.jpg) | ![](/images/61671/143477_B_7_2_rna_selected_60x60.jpg) | Group enriched |
TUBB4A | Tubulin, beta 4A class IVa | Disease related genes Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/10768/25200_B_9_1_rna_selected_60x60.jpg) | Group enriched |
MLC1 | Megalencephalic leukoencephalopathy with subcortical cysts 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/67533/150383_B_8_2_rna_selected_60x60.jpg) | Group enriched |
SLC1A6 | Solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 | Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/41505/91980_B_8_1_rna_selected_60x60.jpg) | Group enriched |
PNMA5 | Paraneoplastic Ma antigen family member 5 | | | ![](/images_static/na_center.gif) | | ![](/images/44690/100195_A_2_3_rna_selected_60x60.jpg) | Group enriched |
NSG2 | Neuron-specific protein family member 2 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/56191/129029_B_8_1_rna_selected_60x60.jpg) | Group enriched |
ELAVL2 | ELAV like neuron-specific RNA binding protein 2 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/22222/151895_A_2_7_rna_selected_60x60.jpg) | Group enriched |
FSTL5 | Follistatin-like 5 | Predicted secreted proteins
| | ![](/images/46724/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/46724/106714_B_9_1_rna_selected_60x60.jpg) | Group enriched |
NPY | Neuropeptide Y | Plasma proteins Predicted secreted proteins
| | | | ![](/images/56798/136001_A_2_6_rna_selected_60x60.jpg) | Group enriched |
ARPP21 | CAMP-regulated phosphoprotein, 21kDa | | | ![](/images/17303/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/17303/142189_B_8_3_rna_selected_60x60.jpg) | Group enriched |
GLRA2 | Glycine receptor, alpha 2 | FDA approved drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images/53525/ihc_cell_selected_60x60.jpg) | ![](/images/53525/135622_A_2_5_rna_selected_60x60.jpg) | Group enriched |
RBFOX1 | RNA binding protein, fox-1 homolog (C. elegans) 1 | | | ![](/images/40809/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/40809/88417_B_8_6_rna_selected_60x60.jpg) | Group enriched |
INA | Internexin neuronal intermediate filament protein, alpha | | | | ![](/images_static/rna_center.gif) | ![](/images/2059/5533_B_1_4_rna_selected_60x60.jpg) | Group enriched |
KCNQ2 | Potassium voltage-gated channel, KQT-like subfamily, member 2 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images/57112/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/57112/140451_B_8_1_rna_selected_60x60.jpg) | Group enriched |
CAMK2A | Calcium/calmodulin-dependent protein kinase II alpha | Enzymes Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/53973/127623_A_6_2_rna_selected_60x60.jpg) | Group enriched |
DLGAP3 | Discs, large (Drosophila) homolog-associated protein 3 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/26445/57583_A_4_3_rna_selected_60x60.jpg) | Group enriched |
NXPH2 | Neurexophilin 2 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/34759/153462_B_8_2_rna_selected_60x60.jpg) | Group enriched |
PPP1R17 | Protein phosphatase 1, regulatory subunit 17 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/47819/109921_B_1_3_rna_selected_60x60.jpg) | Group enriched |
SH3GL3 | SH3-domain GRB2-like 3 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/39381/140617_B_8_3_rna_selected_60x60.jpg) | Group enriched |
ADD2 | Adducin 2 (beta) | Cytoskeleton related proteins
| | ![](/images_static/na_center.gif) | | ![](/images/9796/24747_B_1_7_rna_selected_60x60.jpg) | Group enriched |
SLC6A1 | Solute carrier family 6 (neurotransmitter transporter), member 1 | FDA approved drug targets Predicted membrane proteins Transporters
| | ![](/images/13341/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/22293/56979_B_8_5_rna_selected_60x60.jpg) | Group enriched |
AQP4 | Aquaporin 4 | Predicted membrane proteins Transporters
| | | ![](/images/14784/ihc_cell_selected_60x60.jpg) | ![](/images/14784/141532_B_8_3_rna_selected_60x60.jpg) | Group enriched |
MDGA2 | MAM domain containing glycosylphosphatidylinositol anchor 2 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/3084/8793_B_9_4_rna_selected_60x60.jpg) | Group enriched |
NEUROD1 | Neuronal differentiation 1 | Disease related genes Transcription factors
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/3278/10188_B_8_5_rna_selected_60x60.jpg) | Group enriched |
SPHKAP | SPHK1 interactor, AKAP domain containing | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42499/93363_B_8_1_rna_selected_60x60.jpg) | Group enriched |
TMCC2 | Transmembrane and coiled-coil domain family 2 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14254/33373_B_8_2_rna_selected_60x60.jpg) | Group enriched |
CNDP1 | Carnosine dipeptidase 1 (metallopeptidase M20 family) | Enzymes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/8933/24067_A_4_5_rna_selected_60x60.jpg) | Group enriched |
FGF1 | Fibroblast growth factor 1 (acidic) | Cancer-related genes FDA approved drug targets RAS pathway related proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/17519/39213_A_4_6_rna_selected_60x60.jpg) | Group enriched |
ICAM5 | Intercellular adhesion molecule 5, telencephalin | Plasma proteins Predicted membrane proteins
| | ![](/images/9083/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/25178/57684_B_8_2_rna_selected_60x60.jpg) | Group enriched |
ITPKA | Inositol-trisphosphate 3-kinase A | Enzymes
| | ![](/images/40454/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/40454/144750_A_5_1_rna_selected_60x60.jpg) | Group enriched |
MAG | Myelin associated glycoprotein | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/9345/26745_B_8_5_rna_selected_60x60.jpg) | Group enriched |
RALYL | RALY RNA binding protein-like | | | ![](/images_static/na_center.gif) | ![](/images/55868/ihc_cell_selected_60x60.jpg) | ![](/images/55868/133057_A_4_6_rna_selected_60x60.jpg) | Group enriched |
S100B | S100 calcium binding protein B | Cancer-related genes Candidate cardiovascular disease genes
| | | ![](/images/73/ihc_cell_selected_60x60.jpg) | ![](/images/73/1482_B_5_5_rna_selected_60x60.jpg) | Group enriched |
ADCY8 | Adenylate cyclase 8 (brain) | Enzymes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/24291/53337_B_8_1_rna_selected_60x60.jpg) | Group enriched |
ATP1A3 | ATPase, Na+/K+ transporting, alpha 3 polypeptide | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/33630/80314_A_2_7_rna_selected_60x60.jpg) | Group enriched |
CADM3 | Cell adhesion molecule 3 | Predicted membrane proteins Predicted secreted proteins
| | ![](/images/2981/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/2981/8435_B_7_8_rna_selected_60x60.jpg) | Group enriched |
CAMK2B | Calcium/calmodulin-dependent protein kinase II beta | Enzymes Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/26307/57633_A_5_8_rna_selected_60x60.jpg) | Group enriched |
CARNS1 | Carnosine synthase 1 | Enzymes Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/38569/141858_B_8_2_rna_selected_60x60.jpg) | Group enriched |
DPYSL5 | Dihydropyrimidinase-like 5 | Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/34544/73319_A_4_8_rna_selected_60x60.jpg) | Group enriched |
FAIM2 | Fas apoptotic inhibitory molecule 2 | Predicted membrane proteins
| | ![](/images/18790/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/18790/42240_B_9_4_rna_selected_60x60.jpg) | Group enriched |
FAM69C | Family with sequence similarity 69, member C | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48928/110317_B_7_8_rna_selected_60x60.jpg) | Group enriched |
GLDC | Glycine dehydrogenase (decarboxylating) | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | ![](/images_static/na_center.gif) | | ![](/images/52887/143241_B_7_4_rna_selected_60x60.jpg) | Group enriched |
KLHL32 | Kelch-like family member 32 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/39150/86331_A_8_3_rna_selected_60x60.jpg) | Group enriched |
NRIP3 | Nuclear receptor interacting protein 3 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/40573/86487_B_7_8_rna_selected_60x60.jpg) | Group enriched |
PAX6 | Paired box 6 | Disease related genes Transcription factors
| | | ![](/images_static/rna_center.gif) | ![](/images/30775/68206_B_9_3_rna_selected_60x60.jpg) | Group enriched |
PTPRN | Protein tyrosine phosphatase, receptor type, N | Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/7179/ihc_cell_selected_60x60.jpg) | ![](/images/7179/18672_A_1_2_rna_selected_60x60.jpg) | Group enriched |
PTPRZ1 | Protein tyrosine phosphatase, receptor-type, Z polypeptide 1 | Enzymes Plasma proteins Predicted membrane proteins
| | ![](/images/15103/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/15103/34334_B_8_5_rna_selected_60x60.jpg) | Group enriched |
SYNGR3 | Synaptogyrin 3 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/34278/80296_B_8_2_rna_selected_60x60.jpg) | Group enriched |
TMEM179 | Transmembrane protein 179 | Predicted membrane proteins
| | ![](/images/2942/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/2942/7689_B_8_6_rna_selected_60x60.jpg) | Group enriched |
UCHL1 | Ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | ![](/images/2580/6512_B_7_1_rna_selected_60x60.jpg) | Group enriched |